XML Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Buy
1,921
+330
+21% +$337K 0.17% 118
2026
Q1
$1.46M Sell
1,591
-73
-4% -$74K 0.12% 156
2025
Q4
$1.79M Buy
1,664
+289
+21% +$276K 0.15% 133
2025
Q3
$1.05M Sell
1,375
-295
-18% -$220K 0.09% 179
2025
Q2
$1.3M Hold
1,670
0.11% 154
2025
Q1
$1.38M Sell
1,670
-155
-8% -$129K 0.13% 143
2024
Q4
$1.41M Buy
1,825
+50
+3% +$41.4K 0.13% 142
2024
Q3
$1.57M Buy
1,775
+17
+1% +$15.3K 0.15% 136
2024
Q2
$1.59M Hold
1,758
0.16% 130
2024
Q1
$1.37M Buy
1,758
+261
+17% +$186K 0.14% 138
2023
Q4
$873K Sell
1,497
-69
-4% -$40.3K 0.09% 174
2023
Q3
$841K Sell
1,566
-100
-6% -$51.5K 0.1% 169
2023
Q2
$781K Sell
1,666
-17
-1% -$7.13K 0.09% 179
2023
Q1
$578K Buy
1,683
+100
+6% +$33.7K 0.07% 199
2022
Q4
$579K Buy
1,583
+30
+2% +$10.6K 0.07% 197
2022
Q3
$502K Buy
1,553
+630
+68% +$200K 0.07% 197
2022
Q2
$299K Sell
923
-559
-38% -$168K 0.07% 174
2022
Q1
$424K Buy
1,482
+295
+25% +$75.9K 0.05% 226
2021
Q4
$328K Buy
1,187
+1
+0.1% +$254 0.04% 249
2021
Q3
$274K Buy
+1,186
New +$293K 0.04% 256

Other funds holding LLY

XML Financial's LLY Position: Q2 2026 in Review

XML Financial increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $337K and bringing the position to 1,921 shares worth $2.3M. The position accounts for 0.17% of the portfolio, ranked #118.

XML Financial first reported a position in LLY in Q3 2021 and has held it in 20 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • XML Financial held 1,921 shares of Eli Lilly worth $2.3M as of Q2 2026.
  • XML Financial bought 330 Eli Lilly shares in Q2 2026, an estimated $337K.
  • Eli Lilly made up 0.17% of XML Financial's portfolio in Q2 2026, its #118 holding.
  • XML Financial first reported a position in Eli Lilly in Q3 2021 and has held it in 20 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on XML Financial's 13F filing for Q2 2026, filed 24 Jul 2026.